Extrapyramidal Symptoms as a Result of Risperidone Discontinuation During Combination Therapy with Methylphenidate in a Pediatric Patient

J Child Adolesc Psychopharmacol. 2016 Mar;26(2):182. doi: 10.1089/cap.2015.0225. Epub 2016 Feb 12.

Authors

Carlos A Pérez¹, Sean S Garcia², Regina D Yu³

Affiliations

¹ 1 Division of Child and Adolescent Neurology, University of Texas Health Science Center at Houston , Houston, Texas.
² 2 Department of Pharmacy, Clear Lake Regional Medical Center , Webster, Texas.
³ 3 Division of Community and General Pediatrics, Department of Pediatrics, University of Texas Health Science Center at Houston , Houston, Texas.

PMID: 26871198
DOI: 10.1089/cap.2015.0225

No abstract available

Publication types

Case Reports

MeSH terms

Adolescent
Antipsychotic Agents / administration & dosage
Antipsychotic Agents / adverse effects*
Basal Ganglia Diseases / chemically induced*
Central Nervous System Stimulants / administration & dosage
Drug Therapy, Combination
Humans
Male
Methylphenidate / administration & dosage*
Risperidone / administration & dosage
Risperidone / adverse effects*

Substances

Antipsychotic Agents
Central Nervous System Stimulants
Methylphenidate
Risperidone